Author Interview: Professor Roy Fleischmann – March 2022
Professor Roy Fleishmann, clinical professor of medicine at the University of Texas Southwestern Medical Center.
Here you will find a range of CSF podcasts recorded by our steering committee members and other notable authors.
Professor Roy Fleishmann, clinical professor of medicine at the University of Texas Southwestern Medical Center.
Prof Iain McInnes reviews two papers this month, both on tofacitinib. The first looks at CV outcomes from the STAR-RA study, the second is a post-hoc analysis of ORAL Sequel looking into tofacitinib dose switching.
Professor Rüdiger Müller, Rheumazentrum Ostschweiz, Switzerland
Professor Roy Fleishmann, clinical professor of medicine at the University of Texas Southwestern Medical Center.
Professor Kevin Winthrop, Professor of Medicine at Oregon Health & Science University.
Prof Iain McInnes reviews two papers this month, and discusses the risk of herpes zoster (HZ) events in patients with RA treated with tofacitinib, as well as interstitial lung disease, an extra-articular manifestation of RA.